PATENT CLAIM ANALYSIS

Application Number: 16168671
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-05
Patent Classification: ["514", "04400A"]

Abstract:
This invention relates to compounds, compositions, and methods useful for reducing transth:yretin (TTR) target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.

Claim (Index 68):
The method of  claim 67 , wherein said dsNA is formulated in a lipid nanoparticle (LNP).

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.18182
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15102181', '14583200', '15616254', '15572663', '15044538']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8864908928995279
- 35 USC 102 Novelty (BERT): 0.669066873152159
- Combined Prediction Score: 0.864748490924791
- Mean Citation Score: 733.447494
- Max Citation Score: 866.9187
- Similarity Product: 626.8406528821348

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test